Integration site-independent enhancement of latency reversal by HIV-1 Nef

Integration site-independent enhancement of latency reversal by HIV-1 Nef

Bibliographic Details
Main Authors:	X.T. Kuang, S.W. Jin, T.M. Markle, M.A. Brockman
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S205566402030577X

Similar Items

36 Dose-dependent effects of HDACi on T cell activation and HIV latency reversal
by: X.T. Kuang, et al.
Published: (2016-07-01)

19 HIV-1 Nef enhances viral reactivation and downregulates HLA class I: a dual role in modulating immune-mediated clearance of reservoirs
by: XiaomeiT Kuang, et al.
Published: (2017-07-01)

Attenuation of multiple Nef functions in HIV-1 elite controllers
by: Mwimanzi Philip, et al.
Published: (2013-01-01)

Impairment of viral replication capacity by <it>nef</it> alleles from HIV elite controllers
by: Walker Bruce, et al.
Published: (2011-10-01)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016-07-01)

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
by: Delon Naicker, et al.
Published: (2023-03-01)

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
by: Naicker, Delon, et al.
Published: (2023)

Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity
by: Steven W. Jin, et al.
Published: (2019-11-01)

Human Leukocyte Antigen (HLA) Class I Down-Regulation by Human Immunodeficiency Virus Type 1 Negative Factor (HIV-1 Nef): What Might We Learn From Natural Sequence Variants?
by: Philip Mwimanzi, et al.
Published: (2012-09-01)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
by: Catherine A. Lewis, et al.
Published: (2023-07-01)

HIV-1 Nef: at the crossroads
by: Garcia J Victor, et al.
Published: (2008-09-01)

Nef and HIV/SIV Replication
by: Peterlin Matija
Published: (2005-12-01)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences
by: Macdonald Mahiti, et al.
Published: (2016-03-01)

The enhancement of HIV-1 infectivity by Nef depends on dynamin 2
by: Calistri Arianna, et al.
Published: (2006-12-01)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017-12-01)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016-07-01)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
by: Altfeld M, et al.
Published: (2009-10-01)

OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022-12-01)

The Nef activity on HIV-1 infectivity
by: Stéphane eBasmaciogullari, et al.
Published: (2014-05-01)

Attenuated HIV-1 Nef But Not Vpu Function in a Cohort of Rwandan Long-Term Survivors
by: Gisele Umviligihozo, et al.
Published: (2022-06-01)

Enhancing HIV-1 Nef Penetration into Mammalian Cells as an Antigen Candidate
by: Saba Davoodi, et al.
Published: (2019-01-01)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
by: Ole S Søgaard, et al.
Published: (2015-09-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)

Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products
by: Khumoekae Richard, et al.
Published: (2018-06-01)

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
by: Jared P. Taylor, et al.
Published: (2020-12-01)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
by: Renée M Van der Sluis, et al.
Published: (2020-02-01)

The role of Nef protein in the pathogenesis of HIV infection
by: Rajapaksa, U
Published: (2013)

TNF and HIV-1 Nef: An Intimate Interplay
by: Georges Herbein
Published: (2016-11-01)

Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages
by: Suzu Shinya, et al.
Published: (2011-06-01)

Chemotactic activity of HIV-1 Nef for human monocytes
by: Gluckman JC, et al.
Published: (2006-12-01)

HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
by: Paul W. Denton
Published: (2022-05-01)

AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4
by: Balaji Olety, et al.
Published: (2023-02-01)

Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.
by: Mann, J, et al.
Published: (2013)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
by: Sushant Khanal, et al.
Published: (2021-02-01)

Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5
by: Yuanfei Wu, et al.
Published: (2019-06-01)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015-12-01)

The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells
by: Dennis C. Copertino Jr., et al.
Published: (2023-09-01)

HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy
by: Manish K. Gupta, et al.
Published: (2017-08-01)

Optimal Control of an HIV Model with Gene Therapy and Latency Reversing Agents
by: Zachary Abernathy, et al.
Published: (2021-11-01)